Cargando…

Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells

Neoplastic cells frequently have an increased number of transferrin receptors. Coupling transferrin to an anti-neoplastic drug has the potential to overcome multidrug resistance (MDR). The purpose of this study was to examine the distribution and action of doxorubicin-transferrin conjugate (DOXTRF)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Łubgan, Dorota, Jóźwiak, Zofia, Grabenbauer, Gerhard G., Distel, Luitpold V. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SP Versita 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275917/ https://www.ncbi.nlm.nih.gov/pubmed/18850074 http://dx.doi.org/10.2478/s11658-008-0037-2

Ejemplares similares

Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin
por: Szwed, Marzena, et al.
Publicado: (2014)

Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation
por: Szwed, Marzena, et al.
Publicado: (2015)

Feasibility of a 12-month-exercise intervention during and after radiation and chemotherapy in cancer patients: impact on quality of life, peak oxygen consumption, and body composition
por: Grabenbauer, Alexander, et al.
Publicado: (2016)

Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
por: Soe, Zar Chi, et al.
Publicado: (2019)

Preoperative Radiochemotherapy in Rectal Cancer: Is There an Impact of Oxaliplatin on Pathologic Complete Response and Survival Rates under “Real World“ Conditions?
por: Grabenbauer, Alexander, et al.
Publicado: (2023)

Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers
por: Huang, Wenjing, et al.
Publicado: (2018)

Capsaicin and Piperine Can Overcome Multidrug Resistance in Cancer Cells to Doxorubicin
por: Li, Hanmei, et al.
Publicado: (2018)

Development of Polymersomes Co-Delivering Doxorubicin and Melittin to Overcome Multidrug Resistance
por: Han, Eunkyung, et al.
Publicado: (2023)

Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia
por: Haas, Matthias, et al.
Publicado: (2009)

Distribution of immune cells in head and neck cancer: CD8(+ )T-cells and CD20(+ )B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma
por: Pretscher, Dominik, et al.
Publicado: (2009)

Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen
por: Wang, He-Wen, et al.
Publicado: (2020)

Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance
por: Wang, He, et al.
Publicado: (2014)

Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer
por: GUO, YAJUN, et al.
Publicado: (2015)

PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma
por: Göbel, Holger H., et al.
Publicado: (2022)

A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy
por: Pramanik, Dipankar, et al.
Publicado: (2012)

Doxorubicin–transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells
por: Wigner, Paulina, et al.
Publicado: (2021)

Green Tea Catechin-Based Complex Micelles Combined with Doxorubicin to Overcome Cardiotoxicity and Multidrug Resistance
por: Cheng, Tangjian, et al.
Publicado: (2016)

Chitosan-Based Polyelectrolyte Complexes for Doxorubicin and Zoledronic Acid Combined Therapy to Overcome Multidrug Resistance
por: Giarra, Simona, et al.
Publicado: (2018)

[(WR)(8)WKβA]-Doxorubicin Conjugate: A Delivery System to Overcome Multi-Drug Resistance against Doxorubicin
por: Zoghebi, Khalid, et al.
Publicado: (2022)

Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy
por: Li, Xin, et al.
Publicado: (2018)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.
por: Ramu, A., et al.
Publicado: (1984)

Chemotherapeutic efficacy of the protein-doxorubicin conjugates on multidrug resistant rat hepatoma cell line in vitro.
por: Ohkawa, K., et al.
Publicado: (1993)

A Danshensu-Tetramethylpyrazine Conjugate DT-010 Overcomes Multidrug Resistance in Human Breast Cancer
por: Zhou, Xinhua, et al.
Publicado: (2019)

Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.
por: Suzuki, S., et al.
Publicado: (1997)

Cymbopogon citratus and Citral Overcome Doxorubicin Resistance in Cancer Cells via Modulating the Drug’s Metabolism, Toxicity, and Multidrug Transporters
por: Mukhtar, Mohammed Hasan, et al.
Publicado: (2023)

The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines
por: Kostrzewa-Nowak, D, et al.
Publicado: (2005)

A synthetic antibiotic class overcoming bacterial multidrug resistance
por: Mitcheltree, Matthew J., et al.
Publicado: (2021)

Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
por: Ramalho, Maria João, et al.
Publicado: (2022)

Docetaxel-Loaded Chitosan-Cholesterol Conjugate-Based Self-Assembled Nanoparticles for Overcoming Multidrug Resistance in Cancer Cells
por: Mu, Chao-Feng, et al.
Publicado: (2020)

Overcoming Multidrug Resistance in Cancer Stem Cells
por: Moitra, Karobi
Publicado: (2015)

Pharmacological Strategies for Overcoming Multidrug Resistance to Chemotherapy
por: Fedotcheva, T. A., et al.
Publicado: (2023)

Combination strategies to overcome drug resistance in FLT(+) acute myeloid leukaemia
por: Yang, Jingmei, et al.
Publicado: (2023)

Doxorubicin-conjugated dexamethasone induced MCF-7 apoptosis without entering the nucleus and able to overcome MDR-1-induced resistance
por: Chaikomon, Kamontip, et al.
Publicado: (2018)

Antitumour Effects of Selected Pyridinium Salts on Sensitive Leukaemia HL60 Cells and Their Multidrug Resistant Topoisomerase II-Defective HL60/MX2 Counterparts
por: Tarasiuk, Jolanta, et al.
Publicado: (2022)

Stimuli-responsive nanodrug self-assembled from amphiphilic drug-inhibitor conjugate for overcoming multidrug resistance in cancer treatment
por: Huang, Ping, et al.
Publicado: (2019)

Vancomycin Resistance Is Overcome by Conjugation of Polycationic Peptides
por: Umstätter, Florian, et al.
Publicado: (2020)

Electron spin resonance studies on caeruloplasmin and iron transferrin in patients with chronic lymphocytic leukaemia.
por: Green, J. A., et al.
Publicado: (1980)

Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics
por: Lin, Gan, et al.
Publicado: (2016)

Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
por: Zhou, Lei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ujihnhorrh0ea7nj4tu56225nk